Article
Immunology
Renan Marrichi Mauch, Peter ostrup Jensen, Tavs Qvist, Mette Kolpen, Claus Moser, Tacjana Pressler, Marcos Tadeu Nolasco da Silva, Niels Hoiby, Copenhagen Study Grp Mycobacterial Infect Cyst Fibrosis
Summary: This study aimed to investigate the adaptive immune response to Mycobacterium abscessus complex (MABSC) and its cross-reactivity with Mycobacterium avium complex (MAC) and Mycobacterium bovis (BCG) in cystic fibrosis (CF) patients and non-CF controls. The results showed a similar immune response pattern in CF patients with MABSC and BCG-vaccinated controls, suggesting cross-reactivity. Importance: 6/10.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
(2022)
Article
Multidisciplinary Sciences
Josephine M. Bryant, Karen P. Brown, Sophie Burbaud, Isobel Everall, Juan M. Belardinelli, Daniela Rodriguez-Rincon, Dorothy M. Grogono, Chelsea M. Peterson, Deepshikha Verma, Ieuan E. Evans, Christopher Ruis, Aaron Weimann, Divya Arora, Sony Malhotra, Bridget Bannerman, Charlotte Passemar, Kerra Templeton, Gordon MacGregor, Kasim Jiwa, Andrew J. Fisher, Tom L. Blundell, Diane J. Ordway, Mary Jackson, Julian Parkhill, R. Andres Floto
Summary: The study suggests that epigenetic modifiers acquired through horizontal gene transfer can lead to sudden increases in the pathogenic potential of specific environmental clones, while allopatric parallel evolution during chronic lung infection promotes rapid increases in virulence. The findings indicate that constrained pathogenic evolution is observed while person-to-person transmission remains indirect.
Article
Respiratory System
Rebecca M. Davidson, Nabeeh A. Hasan, L. Elaine Epperson, Jeanne B. Benoit, Sara M. Kammlade, Adrah R. Levin, Vinicius Calado de Moura, Joshua Hunkins, Natalia Weakly, Sean Beagle, Scott D. Sagel, Stacey L. Martiniano, Max Salfinger, Charles L. Daley, Jerry A. Nick, Michael Strong
Summary: The study identified dominant circulating clones of two subspecies of Mycobacterium abscessus in U.S. cystic fibrosis patients, with evidence of shared strains between patients in CF Care Centers. The presence of these dominant clones suggests the potential for transmission events within healthcare settings and the environment.
ANNALS OF THE AMERICAN THORACIC SOCIETY
(2021)
Article
Immunology
Arthur W. Baker, Eileen K. Maziarz, Sarah S. Lewis, Jason E. Stout, Deverick J. Anderson, Peter K. Smith, Jacob N. Schroder, Mani A. Daneshmand, Barbara D. Alexander, Richard J. Wallace, Daniel J. Sexton, Cameron R. Wolfe
Summary: Retrospective analysis of clinical data on patients with post-cardiac surgery Mycobacterium abscessus subspecies abscessus infection revealed significant morbidity and mortality. Urgent need for new treatment strategies and strict compliance with infection prevention guidelines.
CLINICAL INFECTIOUS DISEASES
(2021)
Article
Microbiology
Patricia M. M. Lenhart-Pendergrass, Kenneth C. C. Malcolm, Emily Wheeler, Noel M. M. Rysavy, Katie Poch, Silvia Caceres, Kara M. M. Calhoun, Stacey L. L. Martiniano, Jerry A. A. Nick
Summary: This study investigated the immune response to Mycobacterium avium in cystic fibrosis (CF). Neutrophils in the presence of complement factors, including C3 and IgM, efficiently killed M. avium in healthy individuals, but CF patients had significantly lower killing efficiency. These findings contribute to our understanding of the immune response to M. avium and provide insights for improving diagnostic and treatment strategies.
MICROBIOLOGY SPECTRUM
(2023)
Article
Respiratory System
Kartik Kumar, Charles L. Daley, David E. Griffith, Michael R. Loebinger
Summary: Nontuberculous mycobacterial pulmonary disease (NTM-PD) is a challenging condition to diagnose and treat. The treatment process is prolonged and often accompanied by adverse effects. This review considers the factors influencing clinicians when treating NTM-PD and discusses the outcomes of key studies on the pharmacological management of different types of NTM-PD.
EUROPEAN RESPIRATORY REVIEW
(2022)
Article
Microbiology
Kelley Hurst-Hess, Amanda Walz, Yong Yang, Helen McGuirk, Mercedes Gonzalez-Juarrero, Graham F. Hatfull, Pallavi Ghosh, Anil K. Ojha
Summary: In this study, it was found that a mycobacteriophage-encoded lysin B efficiently kills Mycobacterium abscessus and reduces the bacterial load in mice, suggesting its potential as a treatment for pulmonary M. abscessus infections.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
(2023)
Article
Immunology
Bubacarr J. B. Touray, Mostafa Hanafy, Yashdeep Phanse, Rachel Hildebrand, Adel M. Talaat
Summary: A nanoadjuvant system called QTAP, consisting of Quil-A and DOTAP, was developed for efficient delivery of mRNA vaccine constructs. The system showed high transfection efficiency and protein translation ability. In mice experiments, QTAP nanovaccines induced strong antibody and cytokine responses, and effectively reduced mycobacterial counts in the lungs and spleens. Overall, QTAP is a highly efficient transfection agent that improves the immunogenicity of mRNA vaccines against pulmonary tuberculosis.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Microbiology
Stephen Adonai Leon-Icaza, Salimata Bagayoko, Romain Verge, Nino Iakobachvili, Chloe Ferrand, Talip Aydogan, Celia Bernard, Angelique Sanchez Dafun, Marlene Murris-Espin, Julien Mazieres, Pierre Jean Bordignon, Serge Mazeres, Pascale Bernes-Lasserre, Victoria Rame, Jean-Michel Lagarde, Julien Marcoux, Marie-Pierre Bousquet, Christian Chalut, Christophe Guilhot, Hans Clevers, Peter J. Peters, Virginie Molle, Geanncarlo Lugo-Villarino, Kaymeuang Cam, Laurence Berry, Etienne Meunier, Celine Cougoule
Summary: Although Mabs infection can induce oxidative stress, pharmacological activation of antioxidant pathways can better control Mabs growth and reduce its virulence. Genetic and pharmacological inhibition of CFTR is associated with improved Mabs growth and increased virulence. Pharmacological activation of antioxidant pathways can inhibit Mabs growth and improve efficacy when combined with cefoxitin.
Article
Microbiology
Uday S. Ganapathy, Martin Gengenbacher, Thomas Dick
Summary: Benzoxaboroles, including the clinical candidate epetraborole, have shown activity against Mycobacterium abscessus, expanding the options for developing benzoxaborole-based candidates to treat M. abscessus lung disease.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
(2021)
Article
Microbiology
Nils Wetzstein, Margo Diricks, Thomas A. Kohl, Thomas A. Wichelhaus, Soenke Andres, Laura Paulowski, Carsten Schwarz, Astrid Lewin, Jan Kehrmann, Barbara C. Kahl, Karl Dichtl, Christian Huegel, Olaf Eickmeier, Christina Smaczny, Annika Schmidt, Stefan Zimmermann, Lutz Naehrlich, Sylvia Hafkemeyer, Stefan Niemann, Florian P. Maurer, Michael Hogardt
Summary: This study investigated the epidemiological situation of M. abscessus among CF patients in Germany by performing whole-genome sequencing of isolates. The study identified representatives of all reported DCCs but found no evidence for nosocomial transmission.
MICROBIOLOGY SPECTRUM
(2022)
Article
Immunology
Astrid Lewin, Elisabeth Kamal, Torsten Semmler, Katja Winter, Sandra Kaiser, Hubert Schafer, Lei Mao, Patience Eschenhagen, Claudia Grehn, Jennifer Bender, Carsten Schwarz
Summary: The study on Mycobacterium abscessus infections in Cystic Fibrosis patients revealed an accumulation of gene mutations during chronic lung infection, emphasizing the need for increased attention to genetic diversity during new control strategies against these infections. The strategy of M. abscessus populations in chronic lung infection involves maintaining a wide range of genetic variants for adaptation to changing living conditions in the lung, rather than clonal expansion of dominant variants.
Article
Multidisciplinary Sciences
Margo Diricks, Matthias Merker, Nils Wetzstein, Thomas A. Kohl, Stefan Niemann, Florian P. Maurer
Summary: The authors developed a core-genome multilocus sequence typing scheme for Mycobacterium abscessus to facilitate standardized molecular surveillance. They validated the scheme using whole genome sequencing data, re-analyzed global population structure, and set genetic distance thresholds for cluster detection and taxonomic identification. The scheme can help unravel the global spread of certain clonal complexes and transmission routes.
NATURE COMMUNICATIONS
(2022)
Article
Biochemistry & Molecular Biology
Jerry A. Nick, Rebekah M. Dedrick, Alice L. Gray, Eszter K. Vladar, Bailey E. Smith, Krista G. Freeman, Kenneth C. Malcolm, L. Elaine Epperson, Nabeeh A. Hasan, Jo Hendrix, Kimberly Callahan, Kendra Walton, Brian Vestal, Emily Wheeler, Noel M. Rysavy, Katie Poch, Silvia Caceres, Valerie K. Lovell, Katherine B. Hisert, Vinicius Calado de Moura, Delphi Chatterjee, Prithwiraj De, Natalia Weakly, Stacey L. Martiniano, David A. Lynch, Charles L. Daley, Michael Strong, Fan Jia, Graham F. Hatfull, Rebecca M. Davidson
Summary: This study describes a successful phage treatment of treatment-refractory Mycobacterium abscessus pulmonary infection in a patient with severe lung disease. The phages used in the treatment were engineered to enhance their ability to lyse M. abscessus and were specifically selected based on their effectiveness against the patient's bacterial isolate. The treatment resulted in genetic stability of the bacterial isolate and improved clinical symptoms in the patient.
Article
Respiratory System
Ho Namkoong, Yosuke Omae, Takanori Asakura, Makoto Ishii, Shoji Suzuki, Kozo Morimoto, Yosuke Kawai, Katsura Emoto, Andrew J. Oler, Eva P. Szymanski, Mitsunori Yoshida, Shuichi Matsuda, Kazuma Yagi, Isano Hase, Tomoyasu Nishimura, Yuka Sasaki, Takahiro Asami, Tetsuya Shiomi, Hiroaki Matsubara, Hisato Shimada, Junko Hamamoto, Byung Woo Jhun, Su-Young Kim, Hee Jae Huh, Hong-Hee Won, Manabu Ato, Kenjiro Kosaki, Tomoko Betsuyaku, Koichi Fukunaga, Atsuyuki Kurashima, Herve Tettelin, Hideki Yanai, Surakameth Mahasirimongkol, Kenneth N. Olivier, Yoshihiko Hoshino, Won-Jung Koh, Steven M. Holland, Katsushi Tokunaga, Naoki Hasegawa
Summary: This study identified rs109592 in the CHP2 locus as a susceptibility marker for pulmonary MAC disease.
EUROPEAN RESPIRATORY JOURNAL
(2021)